BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:16:00 PM | Browse: 1243 | Download: 1286
Publication Name World Journal of Hepatology
Manuscript ID 10912
Country Egypt
Received
2014-04-25 08:34
Peer-Review Started
2014-04-28 22:40
To Make the First Decision
2014-05-23 15:11
Return for Revision
2014-08-06 14:16
Revised
2014-08-20 00:00
Second Decision
2014-10-27 16:41
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-10-27 17:01
Articles in Press
2014-10-27 17:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-11-20 09:16
Publish the Manuscript Online
2014-11-20 19:46
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Case Report
Article Title Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma
Manuscript Source Unsolicited Manuscript
All Author List Hassan El-Garem, Ayman Ammer, Hany Shehab, Olfat Shaker, Mohammed Anwer, Wafaa El-Akel and Heba Omar
Funding Agency and Grant Number
Corresponding Author Heba Omar, Msc, PhD, Endemic Medicine and Hepatology Department, Faculty of medicine, 16 Azam Street, Helwan, Cairo 12613, Egypt. hebaomar1202@hotmail.com
Key Words MiRNA; Hepatocellular carcinoma; Serum
Core Tip In the current study a signature of circulating miRNAs (miR-122 and miR-221) was evaluated. miR-221 was differentially expressed between patients with hepatocellular carcinoma and those without (chronic hepatitis and liver cirrhosis) with lower serum level of miR-221 in former group of patients in comparison to later one. miR-221 yielded 87% sensitivity and 40% specificity in differentiating between both groups at a cutoff 1.82 folds. The present study emphasizes that circulating miR-221 deserves further attention as a potential non-invasive biomarkers for hepatocellular carcinoma.
Publish Date 2014-11-20 19:46
Citation El-Garem H, Ammer A, Shehab H, Shaker O, Anwer M, El-Akel W, Omar H. Circulating microRNA, miR-122 and miR-221 signature in Egyptian patients with chronic hepatitis C related hepatocellular carcinoma. World J Hepatol 2014; 6(11): 818-824
URL http://www.wjgnet.com/1948-5182/full/v6/i11/818.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i11.818
Full Article (PDF) WJH-6-818.pdf
Full Article (Word) WJH-6-818.doc
Manuscript File 10912-Review.doc
Answering Reviewers 10912-Answering reviewers.pdf
Copyright License Agreement 10912-Copyright assignment.pdf
Institutional Review Board Approval Form or Document Ethics_Committee_20140425061015.docx
Non-Native Speakers of English Editing Certificate 10912-Language certificate.pdf
Peer-review Report 10912-Peer review(s).pdf
Scientific Misconduct Check 10912-CrossCheck.jpg
Scientific Editor Work List 10912-Scientific editor work list.pdf